or muscarinic activity) potentially targeting 5-HT2A receptors, improved Parkinson's disease psychosis (PDP) with demonstrated safety and tolerability, and without worsening motor Parkinson's, according to data presented in two posters at the 19th International Congress of Parkinson's Diseas...
Utilizing secretomes as a novel molecular-based therapy for Parkinson’s disease: A scoping review Ervina Arta Jayanti Hutabarat, Suroto Suroto, Soetrisno Soetrisno, Diah Kurnia Mirawati, Eti Poncorini Pamungkasari, Brian Wasita DOI:10.7324/JAPS.2025.219807 ...